메뉴 건너뛰기




Volumn 88, Issue 1, 2005, Pages 24-29

Developmental toxicology evaluations - Issues with including neurotoxicology and immunotoxicology assessments in reproductive toxicology studies

Author keywords

Combination study; DART; Developmental and reproductive toxicology; Developmental immunotoxicology; Developmental neurotoxicology; DIT; DNT; Hazard identification; Panel discussion; Study design

Indexed keywords

TOXIN;

EID: 27644436848     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfi299     Document Type: Article
Times cited : (41)

References (26)
  • 6
    • 0034177780 scopus 로고    scopus 로고
    • Testing methods for developmental neurotoxicity of environmental chemicals
    • Claudio, L., Kwa, W. C., Russell, A. L., and Wallinga, D. (2000). Testing methods for developmental neurotoxicity of environmental chemicals. Toxicol. Appl. Pharmacol. 164, 1-14.
    • (2000) Toxicol. Appl. Pharmacol. , vol.164 , pp. 1-14
    • Claudio, L.1    Kwa, W.C.2    Russell, A.L.3    Wallinga, D.4
  • 8
    • 0242661674 scopus 로고    scopus 로고
    • Developmental immunotoxicity of dexamethasone: Compaison of fetal versus adult exposures
    • Dietert, R. R., Lee, J.-E., Olsen, J. Fitch, K., and Marsh, J. A. (2003). Developmental immunotoxicity of dexamethasone: Compaison of fetal versus adult exposures. Toxicology 194, 163-176.
    • (2003) Toxicology , vol.194 , pp. 163-176
    • Dietert, R.R.1    Lee, J.-E.2    Olsen, J.3    Fitch, K.4    Marsh, J.A.5
  • 9
    • 0038144117 scopus 로고    scopus 로고
    • Guidance for Industry - Immunotoxicology evaluation of investigational new drugs
    • Food and Drug Administration (FDA). Office of Training and Communication, Division of Drug Information, Center for Drug Evaluation and Research, U. S. Department of Health and Human Services
    • Food and Drug Administration (FDA). (2002). Guidance for Industry - Immunotoxicology evaluation of investigational new drugs. Office of Training and Communication, Division of Drug Information, Center for Drug Evaluation and Research, U. S. Department of Health and Human Services.
    • (2002)
  • 10
    • 0025006999 scopus 로고
    • Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: Summary and implications
    • Francis, E. Z., Kimmel, C. A., and Rees, D. C (1990). Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity: Summary and implications. Neurotoxicol. Teratol. 12, 285-292.
    • (1990) Neurotoxicol. Teratol. , vol.12 , pp. 285-292
    • Francis, E.Z.1    Kimmel, C.A.2    Rees, D.C.3
  • 11
    • 0036760267 scopus 로고    scopus 로고
    • Developmental immunotoxicology and risk assessment: A workshop summary
    • Holsapple, M. P. (2002). Developmental immunotoxicology and risk assessment: A workshop summary. Human Exp. Toxicol. 21, 473-478.
    • (2002) Human Exp. Toxicol. , vol.21 , pp. 473-478
    • Holsapple, M.P.1
  • 13
    • 10044235266 scopus 로고    scopus 로고
    • Developmental immunotoxicity of cyclosporine-A in rats: Age-associated differential effects
    • Hussain, I., Piepenbrink, M. S., Fitch, K. J., Marsh, J. A., and Dietert, R. R. (2005). Developmental immunotoxicity of cyclosporine-A in rats: Age-associated differential effects. Toxicology 206, 273-284.
    • (2005) Toxicology , vol.206 , pp. 273-284
    • Hussain, I.1    Piepenbrink, M.S.2    Fitch, K.J.3    Marsh, J.A.4    Dietert, R.R.5
  • 14
    • 0000230038 scopus 로고
    • ICH S5A. Detection of toxicity to reproduction for medicinal products
    • International Conference on Harmonization (ICH)
    • International Conference on Harmonization (ICH). (1994). ICH S5A. Detection of toxicity to reproduction for medicinal products. Fed. Regist. 59, 48746-48752.
    • (1994) Fed. Regist. , vol.59 , pp. 48746-48752
  • 15
    • 0025424471 scopus 로고
    • Qualitative and quantitative comparability of human and animal developmental neurotoxicity
    • Kimmel, C. A., Rees, D. C., and Francis, E. Z. (1990). Qualitative and quantitative comparability of human and animal developmental neurotoxicity. Neurotoxicol. Teratol. 12, 173-291.
    • (1990) Neurotoxicol. Teratol. , vol.12 , pp. 173-291
    • Kimmel, C.A.1    Rees, D.C.2    Francis, E.Z.3
  • 16
    • 24644524503 scopus 로고    scopus 로고
    • Risk assessment perspectives for developmental immunotoxicology
    • 1st ed. (S. D. Holladay, Ed.), CRC Press LLC, Boca Raton, FL
    • Kimmel, C. A., King, M. D., and Makris, S. L. (2005). Risk assessment perspectives for developmental immunotoxicology, In Developmental Immunotoxicology, 1st ed. (S. D. Holladay, Ed.), pp. 45-63. CRC Press LLC, Boca Raton, FL.
    • (2005) Developmental Immunotoxicology , pp. 45-63
    • Kimmel, C.A.1    King, M.D.2    Makris, S.L.3
  • 17
    • 0038408633 scopus 로고    scopus 로고
    • Consensus workshop on methods to evaluate developmental immunotoxicity
    • Luster, M. I., Dean, J. H., and Germolec, D. R. (2003). Consensus workshop on methods to evaluate developmental immunotoxicity. Environ. Health Perspect. 111, 579-583.
    • (2003) Environ. Health Perspect. , vol.111 , pp. 579-583
    • Luster, M.I.1    Dean, J.H.2    Germolec, D.R.3
  • 18
    • 0005431786 scopus 로고    scopus 로고
    • A retrospective analysis of twelve developmental neurotoxicity (DNT) studies submitted to the USEPA Office of Prevention, Pesticides and Toxic Substances (OPPTS)
    • Presentation to FIFRA Scientific Advisory Panel, December 9-10, 1998
    • Makris, S., Raffaele, K., Sette, W., and Seed, J. (1998). A retrospective analysis of twelve developmental neurotoxicity (DNT) studies submitted to the USEPA Office of Prevention, Pesticides and Toxic Substances (OPPTS). Presentation to FIFRA Scientific Advisory Panel, December 9-10, 1998. http://www.epa.gov/scipoly/sap/1998/december/ neuro.pdf.
    • (1998)
    • Makris, S.1    Raffaele, K.2    Sette, W.3    Seed, J.4
  • 20
    • 0035047581 scopus 로고    scopus 로고
    • Methods to identify and characterize developmental neurotoxicity for human health risk assessment: An overview
    • Mileson, B. E., and Ferenc, S. A. (2001). Methods to identify and characterize developmental neurotoxicity for human health risk assessment: An overview. Environ. Health Perspect. 109(Suppl. 1), 77-78.
    • (2001) Environ. Health Perspect. , vol.109 , Issue.SUPPL. 1 , pp. 77-78
    • Mileson, B.E.1    Ferenc, S.A.2
  • 21
    • 0003655906 scopus 로고
    • Pesticides in the Diets of Infants and Children
    • National Research Council (NRC). National Academy Press, Washington, DC
    • National Research Council (NRC). (1993). Pesticides in the Diets of Infants and Children. National Academy Press, Washington, DC.
    • (1993)
  • 22
    • 27644524915 scopus 로고    scopus 로고
    • OECD Guideline for the Testing of Chemicals; Proposal for a new guideline 426, Developmental Neurotoxicity Study
    • OECD September 2003
    • OECD (2003). OECD Guideline for the Testing of Chemicals; Proposal for a new guideline 426, Developmental Neurotoxicity Study. September 2003.
    • (2003)
  • 23
  • 25
    • 0037909184 scopus 로고    scopus 로고
    • Health Effects Test Guidelines, OPPTS 870.3800, Reproduction and Fertility Effects
    • U.S. EPA Office of Prevention, Pesticides and Toxic Substances. U.S. Environmental Protection Agency 712-C-98-208
    • U.S. EPA (1998a). Health Effects Test Guidelines, OPPTS 870.3800, Reproduction and Fertility Effects. Office of Prevention, Pesticides and Toxic Substances. U.S. Environmental Protection Agency 712-C-98-208. http://www.epa.gov/opptsfrs/OPPTS_Harmonized/ 870_Health_Effects_Test_Guidelines/Series/.
    • (1998)
  • 26
    • 0004592386 scopus 로고    scopus 로고
    • Health Effects Test Guidelines, OPPTS 870.6300. Developmental Neurotoxicity
    • U.S. EPA Office of Prevention, Pesticides and Toxic Substances. U.S. Environmental Protection Agency 712-C-98-239
    • U.S. EPA (1998b). Health Effects Test Guidelines, OPPTS 870.6300. Developmental Neurotoxicity. Office of Prevention, Pesticides and Toxic Substances. U.S. Environmental Protection Agency 712-C-98-239. http://www.epa.gov/opptsfrs/OPPTS_Harmonized/ 870_Health_Effects_Test_Guidelines/Series/.
    • (1998)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.